Zubair Khalid

Virologist/Molecular Biologist | Veterinarian | Bioinformatician

Conventional & Molecular Virology • Vaccine Development • Computational Biology

Dr. Zubair Khalid is a veterinarian and virologist specializing in conventional and molecular virology, vaccine development, and computational biology. Dedicated to advancing animal health through innovative research and multi-omics approaches.

Dr. Zubair Khalid - Veterinarian, Virologist, and Vaccine Development Researcher specializing in Computational Biology, Multi-omics, Animal Health, and Infectious Disease Research

Section: Clinical Methods & Interventions

Generalized Lymphadenopathy in Veterinary Patients: Cytology, Flow Testing, and Biopsy Decisions

At a Glance

Generalized lymphadenopathy in veterinary patients requires a systematic diagnostic approach to differentiate reactive hyperplasia, infectious causes, and neoplasia. Cytology serves as the first-line test. Flow cytometry provides immunophenotypic characterization when cytology is equivocal. Biopsy remains the gold standard for definitive diagnosis when less invasive methods are inconclusive. The table below summarizes the key features of each diagnostic modality.

Diagnostic Test Sample Type Turnaround Time Key Information Provided Limitations
Fine-needle aspiration cytology Aspirated cells from lymph node 24 to 48 hours Cell morphology, population assessment, initial classification Requires experience for accurate interpretation, cannot assess tissue architecture
Flow cytometry Cell suspension from aspirate or blood 48 to 72 hours Immunophenotype, clonality assessment, cell size and complexity Requires specialized equipment and expertise, not widely available in all regions
Excisional biopsy Whole lymph node 3 to 7 days Complete architecture, histologic grade, immunohistochemistry Invasive procedure requiring anesthesia, higher cost and recovery time

Clinical Presentation and Initial Assessment

Generalized lymphadenopathy refers to enlargement of two or more non-contiguous lymph nodes. In veterinary patients, this finding prompts a differential diagnosis that includes reactive hyperplasia, infectious lymphadenitis, immune-mediated disease, and neoplasia such as lymphoma or metastatic disease. The Merck Veterinary Manual provides foundational guidance on lymph node evaluation in clinical practice [4].

The initial assessment begins with a thorough history and physical examination. Palpation of all accessible lymph nodes including mandibular, prescapular, axillary, inguinal, and popliteal nodes should be performed systematically. Record the size, consistency, mobility, and symmetry of each enlarged node. Nodes that are firm, irregular, or fixed to underlying tissue raise suspicion for neoplasia. Soft, mobile, and symmetric enlargement may suggest reactive hyperplasia.

Signalment and history provide critical context. Young animals are more likely to present with infectious or reactive causes. Older animals have a higher prevalence of neoplasia. Breed predispositions exist for certain lymphoproliferative disorders. Vaccination history, travel history, and exposure to other animals help identify potential infectious causes. The American Veterinary Medical Association offers resources on animal health and welfare that include guidance on infectious disease surveillance [1].

Cytology: First-Line Diagnostic Tool

Sample Collection and Preparation

Fine-needle aspiration of enlarged lymph nodes is a rapid, minimally invasive procedure that can be performed in conscious patients with minimal restraint. Use a 22- to 25-gauge needle attached to a 6- to 12-mL syringe. Insert the needle into the lymph node, apply negative pressure, and redirect the needle several times within the node before releasing suction and withdrawing. Expel the sample onto glass slides and prepare smears using the squash or pull technique.

Air-dried slides can be stained with Romanowsky-type stains such as Diff-Quik for immediate evaluation. For samples that may require special staining, prepare additional unstained slides. The quality of the sample directly affects diagnostic accuracy. Hemodiluted or poorly cellular samples may be nondiagnostic and require repeat aspiration.

Cytologic Interpretation

Normal lymph node cytology shows a predominance of small lymphocytes with fewer medium and large lymphocytes, plasma cells, and occasional macrophages. Reactive hyperplasia presents with increased cellularity, a mixed population of lymphocytes, and increased numbers of plasma cells and tingible-body macrophages. The architecture remains polymorphic with a spectrum of lymphocyte sizes.

Neoplastic populations typically show a monomorphic population of cells. Lymphoma is characterized by a predominance of medium to large lymphocytes with prominent nucleoli, increased mitotic figures, and lymphoglandular bodies. The cytologic classification of lymphoma includes small lymphocytic, large cell, lymphoblastic, and mixed cell types. Metastatic neoplasia may show epithelial cells, melanocytes, or other non-lymphoid cell populations.

A study published in Berliner und Munchener tierarztliche Wochenschrift examined the reliability of lymph node cytology interpretation by investigators with limited cytologic experience. The findings indicated that interpretation accuracy improves with training and experience, highlighting the importance of submitting samples to qualified clinical pathologists [6]. When cytologic findings are ambiguous or inconsistent with the clinical presentation, additional testing is warranted.

Limitations of Cytology

Cytology cannot assess lymph node architecture. Loss of normal follicular architecture is a key histologic feature of lymphoma that cannot be evaluated on aspirate samples. Cytology may also miss partial involvement of a lymph node by neoplasia, leading to false-negative results. Reactive hyperplasia and well-differentiated lymphoma can appear similar on cytology, particularly in cases of small cell lymphoma.

Infectious organisms may be identified on cytology, but sensitivity varies. Bacterial lymphadenitis may show degenerate neutrophils and intracellular bacteria. Fungal organisms such as Histoplasma or Cryptococcus may be visible. Mycobacterial infections often show granulomatous inflammation with acid-fast organisms requiring special stains.

Flow Cytometry: Immunophenotypic Characterization

Principles and Applications

Flow cytometry uses laser-based technology to measure physical and chemical characteristics of cells in suspension. Cells are labeled with fluorescent antibodies against cell surface markers, allowing identification of cell lineages and maturation stages. In veterinary medicine, flow cytometry is increasingly used for immunophenotyping lymph node aspirates and peripheral blood samples.

The technique provides objective, quantitative data on cell populations. It can detect aberrant antigen expression patterns that are characteristic of neoplasia. Clonality assessment using immunoglobulin light chain restriction or T-cell receptor analysis can differentiate reactive from neoplastic populations. A multicenter flow cytometry proficiency testing study of canine blood and lymph node samples demonstrated the importance of standardized protocols and quality control measures across laboratories [9].

Indications for Flow Cytometry

Flow cytometry is indicated when cytology is equivocal, when lymphoma is suspected but cytology shows a mixed population, or when immunophenotype information is needed for prognosis and treatment planning. It is particularly useful in cases where cytology shows a predominance of intermediate to large lymphocytes but cannot definitively distinguish reactive from neoplastic populations.

A case report published in the Journal of Veterinary Clinics described a 12-year-old dog with multicentric lymphadenopathy where cytology showed different cell populations across lymph nodes, including intermediate to large lymphocytes with frequent Mott cells. The presence of Mott cells along with immature lymphocytes made cytologic diagnosis challenging. Flow cytometry, along with PCR for Antigen Receptor Rearrangement (PARR) assay, confirmed the diagnosis of canine multicentric large B-cell lymphoma [12]. This case illustrates the value of flow cytometry in resolving ambiguous cytologic findings.

Sample Requirements and Processing

Flow cytometry requires a cell suspension with adequate viability. Samples can be obtained from fine-needle aspirates, lymph node biopsies, or peripheral blood. Aspirates should be collected into media or saline and kept cool during transport. Samples should be processed within 24 to 48 hours for optimal results.

The panel of antibodies used depends on the species and suspected diagnosis. Common markers for canine lymphoma include CD3, CD4, CD8 for T cells and CD21, CD79a, and MHC II for B cells. Aberrant expression patterns such as loss of CD45 or co-expression of markers from different lineages support a diagnosis of neoplasia.

Limitations of Flow Cytometry

Flow cytometry requires specialized equipment and expertise that may not be available in all clinical settings. Sample quality is critical, low cellularity or poor viability can compromise results. The technique cannot assess lymph node architecture, and some lymphomas may not express the markers included in the panel.

Cost is a consideration for many clients. Flow cytometry is more expensive than cytology but less expensive than histopathology with immunohistochemistry. The clinical utility must be weighed against the cost and availability in each case.

Biopsy Decisions: When and How

Indications for Biopsy

Lymph node biopsy is indicated when cytology and flow cytometry are inconclusive, when a definitive diagnosis is required for treatment planning, or when the clinical presentation suggests a condition that cannot be diagnosed by less invasive methods. Biopsy provides tissue architecture information that is essential for classifying lymphoma subtypes and differentiating reactive from neoplastic conditions.

The decision to proceed with biopsy should be based on the clinical context. If cytology shows a monomorphic population of large lymphocytes consistent with high-grade lymphoma, biopsy may not be necessary before initiating treatment. However, if cytology shows a mixed population or if the clinical course is atypical, biopsy provides definitive diagnosis.

Biopsy Techniques

Excisional biopsy of an entire lymph node is preferred for diagnostic purposes. Select the largest accessible node, avoiding nodes that have been previously aspirated to minimize artifact from hemorrhage and inflammation. The node should be removed intact with careful hemostasis.

Incisional biopsy or core needle biopsy may be used when excisional biopsy is not feasible due to location or patient factors. These techniques provide less tissue and may not capture the full architecture of the node. Place the sample in 10% neutral buffered formalin for histopathology. If flow cytometry or culture is also planned, collect additional samples in appropriate media.

Histopathologic Interpretation

Histopathology allows evaluation of lymph node architecture including follicular structure, paracortical regions, and medullary sinuses. Reactive hyperplasia shows preserved architecture with expanded follicles and germinal centers. Lymphoma shows effacement of normal architecture by a monomorphic population of neoplastic lymphocytes.

Immunohistochemistry can be performed on formalin-fixed tissue to determine immunophenotype. A review and consensus of standard guidelines on epithelial and myoepithelial phenotype markers, HER2, and hormone receptor assessment using immunohistochemistry in canine mammary tumors provides a framework for standardized immunohistochemical evaluation [10]. Similar standardized approaches are used for lymph node evaluation.

Sentinel Lymph Node Biopsy

Sentinel lymph node biopsy is an emerging technique in veterinary surgical oncology. The sentinel node is the first lymph node to receive lymphatic drainage from a primary tumor. Identification and biopsy of the sentinel node allows detection of early metastatic disease. A review published in Veterinaria discussed the rationale and technique for sentinel lymph node biopsy in veterinary patients [13].

The technique involves injection of a contrast agent or dye around the primary tumor, followed by identification of the draining lymph node. The sentinel node is then removed and examined histologically. This approach improves staging accuracy and may guide treatment decisions.

Differential Diagnosis of Generalized Lymphadenopathy

Reactive Hyperplasia

Reactive hyperplasia is the most common cause of generalized lymphadenopathy in veterinary patients. It represents a normal immune response to antigenic stimulation from infection, inflammation, or vaccination. Cytology shows a polymorphic population with increased plasma cells and macrophages. The lymph node architecture remains intact on histopathology.

Common causes include bacterial, viral, or fungal infections, immune-mediated diseases, and recent vaccination. The lymphadenopathy typically resolves when the underlying cause is addressed. Monitoring for resolution over 2 to 4 weeks is appropriate when reactive hyperplasia is suspected.

Infectious Lymphadenitis

Infectious lymphadenitis can be caused by bacteria, fungi, viruses, or parasites. Bacterial lymphadenitis often presents with painful, enlarged nodes that may abscess. Cytology shows suppurative inflammation with degenerate neutrophils and intracellular bacteria. Culture and sensitivity testing guide antimicrobial therapy.

Fungal lymphadenitis is less common but occurs in endemic areas. Histoplasma, Blastomyces, and Cryptococcus can cause granulomatous lymphadenitis. Cytology may show characteristic organisms. Serologic testing and antigen detection assays aid diagnosis.

Mycobacterial lymphadenitis presents with chronic, firm lymphadenopathy. Cytology shows granulomatous inflammation with epithelioid macrophages. Acid-fast staining reveals organisms. Diagnosis requires culture or PCR testing.

Lymphoma

Lymphoma is a common neoplasm of dogs and cats that frequently presents with generalized lymphadenopathy. The Merck Veterinary Manual provides comprehensive information on lymphoma classification and clinical presentation [4]. Cytology typically shows a monomorphic population of neoplastic lymphocytes. Flow cytometry provides immunophenotype information that guides prognosis and treatment.

Multicentric lymphoma involves multiple peripheral lymph nodes. Affected nodes are typically firm, mobile, and non-painful. Systemic signs such as lethargy, anorexia, and weight loss may be present. The diagnosis is confirmed by cytology, flow cytometry, or histopathology.

Metastatic Neoplasia

Metastatic neoplasia to lymph nodes can cause generalized lymphadenopathy. Common primary tumors include melanoma, mast cell tumor, mammary carcinoma, and hemangiosarcoma. Cytology may show epithelial cells, melanocytes, or other non-lymphoid cell populations.

A retrospective study of acute myeloid leukemia with peripheral lymph node involvement in dogs described 23 cases where leukemic cells infiltrated lymph nodes [7]. This condition can present with generalized lymphadenopathy and requires flow cytometry or immunohistochemistry for definitive diagnosis.

Immune-Mediated Disease

Immune-mediated diseases such as systemic lupus erythematosus, immune-mediated polyarthritis, and drug reactions can cause generalized lymphadenopathy. The lymphadenopathy is typically reactive and resolves with treatment of the underlying condition. Cytology shows reactive hyperplasia without evidence of neoplasia.

Diagnostic Workflow

Step 1: History and Physical Examination

Begin with a complete history including signalment, vaccination status, travel history, and exposure to other animals. Perform a thorough physical examination with systematic palpation of all accessible lymph nodes. Record the size, consistency, and distribution of enlarged nodes. Note any systemic signs such as fever, lethargy, or weight loss.

Step 2: Minimum Database

Obtain a complete blood count, serum biochemistry profile, and urinalysis. These tests identify concurrent disease, assess organ function, and may reveal abnormalities suggestive of systemic illness. The complete blood count may show lymphocytosis, lymphopenia, or circulating blast cells in cases of leukemia.

Step 3: Lymph Node Cytology

Perform fine-needle aspiration of the largest accessible lymph node. Submit slides to a clinical pathologist for interpretation. If cytology shows a monomorphic population consistent with lymphoma, proceed to flow cytometry or biopsy for immunophenotyping.

Step 4: Flow Cytometry

If cytology is equivocal or if immunophenotype information is needed, submit a fresh aspirate sample for flow cytometry. Flow cytometry can differentiate reactive from neoplastic populations and determine B-cell or T-cell lineage.

Step 5: Lymph Node Biopsy

If cytology and flow cytometry are inconclusive, or if a definitive histologic diagnosis is required, perform excisional lymph node biopsy. Submit the node in formalin for histopathology and immunohistochemistry.

Step 6: Ancillary Testing

Based on the clinical presentation and initial findings, additional testing may include infectious disease serology, PCR testing for antigen receptor rearrangement, or imaging studies such as thoracic radiographs and abdominal ultrasound for staging.

Records and Measurements

Lymph Node Mapping

Create a standardized lymph node map for each patient. Record the location, size in three dimensions, consistency, and mobility of each palpable node. Use a consistent grading system for lymph node enlargement such as normal, mildly enlarged, moderately enlarged, or markedly enlarged. Document changes over time with serial examinations.

Cytology Records

Maintain a record of all cytology samples including the collection date, site, sample quality, and interpretation. Note any special stains performed and the results. Store representative slides for future reference if needed.

Flow Cytometry Records

Document the antibody panel used, the percentage of cells positive for each marker, and any aberrant expression patterns. Record the final immunophenotype classification. Note any quality control issues such as low viability or insufficient cell numbers.

Biopsy Records

Record the biopsy technique used, the lymph node site, and any complications. Document the histopathologic diagnosis including the lymphoma subtype if applicable. Note any immunohistochemistry results and the markers used.

Common Failure Patterns

Inadequate Sample Quality

Poor sample quality is a common cause of nondiagnostic cytology. Hemodiluted samples, low cellularity, or poorly prepared smears may not be interpretable. Repeat aspiration with attention to technique improves sample quality. For flow cytometry, samples with low viability or insufficient cell numbers may not yield reliable results.

Sampling Error

Aspiration of a reactive node when a neoplastic node is present elsewhere can lead to misdiagnosis. In multicentric disease, different nodes may show different cytologic features. Aspirate multiple nodes if the clinical presentation is atypical. The case report of canine multicentric large B-cell lymphoma with Mott cells highlighted that different lymph nodes showed different cell populations, emphasizing the need for sampling multiple sites [12].

Interpretation Error

Cytologic interpretation requires experience. Well-differentiated lymphoma can be mistaken for reactive hyperplasia. Reactive hyperplasia with marked plasma cell infiltration can mimic neoplasia. Submit samples to a qualified clinical pathologist for interpretation. When cytologic findings do not match the clinical presentation, pursue additional testing.

Incomplete Diagnostic Workup

Skipping steps in the diagnostic workup can lead to incorrect diagnosis. Flow cytometry should be performed when cytology is equivocal. Biopsy should be pursued when less invasive methods are inconclusive. The diagnostic approach should be tailored to each case based on the clinical presentation and available resources.

Welfare and Safety Context

Patient Comfort

Lymph node aspiration is a minimally invasive procedure that can be performed with minimal restraint in most patients. Use a small-gauge needle to minimize discomfort. For patients that are painful or anxious, consider sedation. Excisional biopsy requires general anesthesia and appropriate perioperative pain management.

Biopsy Risks

Lymph node biopsy carries risks including hemorrhage, infection, and seroma formation. The risk is low with careful surgical technique. Patients with coagulopathies should be evaluated before biopsy. The benefits of definitive diagnosis must outweigh the risks of the procedure.

Infection Control

Infectious lymphadenitis may be caused by zoonotic organisms such as Mycobacterium, Brucella, or Yersinia. Use standard precautions when handling lymph node samples. The World Organisation for Animal Health provides guidelines for animal health and welfare that include infection control recommendations [5].

Regulatory Considerations

The American Animal Hospital Association provides resources on standards of care in veterinary practice [2]. The American College of Veterinary Anesthesiologists and Analgesia offers guidance on anesthesia and pain management for surgical procedures [3]. Adherence to professional standards ensures patient safety and welfare.

Professional Escalation Criteria

Urgent Escalation

Refer to a veterinary oncologist or internal medicine specialist when:

  • Cytology shows a monomorphic population consistent with lymphoma
  • Flow cytometry confirms a neoplastic immunophenotype
  • The patient has systemic signs such as fever, lethargy, or weight loss
  • Lymphadenopathy is rapidly progressive
  • There is evidence of organ dysfunction on bloodwork

Routine Escalation

Refer for specialist consultation when:

  • Cytology is equivocal and flow cytometry is not available in-house
  • Biopsy is required but the clinician does not perform the procedure
  • The diagnosis is uncertain after initial diagnostic testing
  • The client desires a second opinion before proceeding with treatment

Monitoring and Follow-Up

Patients with reactive hyperplasia should be re-examined in 2 to 4 weeks to document resolution of lymphadenopathy. If lymphadenopathy persists or progresses, repeat cytology or proceed to biopsy. Patients with confirmed neoplasia should be referred for staging and treatment planning.

Practical Decision Framework for Lymph Node Sampling Site Selection and Diagnostic Yield Optimization

Selecting the correct lymph node for diagnostic sampling directly affects the accuracy of cytology, flow cytometry, and biopsy results. A structured decision framework helps clinicians avoid common sampling errors that lead to nondiagnostic results or misdiagnosis. This section provides a practical approach to lymph node selection, sample quality assessment, and troubleshooting when initial results do not match the clinical picture.

Lymph Node Selection Criteria

Palpation-Based Assessment

Begin with systematic palpation of all accessible lymph node chains. Record the size, consistency, and mobility of each node using a standardized grading system. Nodes that are firm, irregular, or fixed to underlying tissue raise suspicion for neoplasia and should be prioritized for sampling. Soft, mobile, and symmetric enlargement may suggest reactive hyperplasia but does not rule out early neoplastic infiltration.

The Merck Veterinary Manual provides foundational guidance on lymph node evaluation in clinical practice [4]. Use the following palpation grading system for consistent documentation:

  • Grade 0: Not palpable
  • Grade 1: Palpable but normal size
  • Grade 2: Mildly enlarged, less than 2 times normal
  • Grade 3: Moderately enlarged, 2 to 3 times normal
  • Grade 4: Markedly enlarged, greater than 3 times normal

Record the grade for each lymph node chain separately. This allows objective tracking of changes over time and helps identify which nodes are most likely to yield diagnostic samples.

Size and Accessibility Considerations

The largest accessible lymph node is generally the best choice for initial sampling. Larger nodes have higher cellularity and are easier to aspirate accurately. However, avoid nodes that are abscessed, necrotic, or located near major blood vessels. The prescapular and popliteal lymph nodes are often the most accessible in dogs and cats. Mandibular nodes are accessible but may be contaminated by oral flora if the needle passes through the oral mucosa.

For patients with multiple enlarged nodes, sample the node that feels most abnormal on palpation. If all nodes feel similar, sample the largest node that is easiest to access with minimal patient restraint. Document which node was sampled and why it was selected.

Avoiding Previously Aspirated Nodes

Nodes that have been aspirated within the previous 7 to 14 days may show hemorrhage, inflammation, and reactive changes that complicate interpretation. The needle tract can introduce inflammation that mimics pathology or obscures underlying neoplasia. If a previous aspirate was nondiagnostic, select a different node for repeat sampling whenever possible.

If only one node is available and it has been previously aspirated, wait at least 7 days before repeat aspiration. Alternatively, consider proceeding directly to excisional biopsy if the clinical suspicion for neoplasia is high and the node is accessible for surgical removal.

Sample Quality Assessment at Collection

Immediate Evaluation of Aspirate Quality

Assess sample quality immediately after collection to determine if repeat aspiration is needed. A good-quality aspirate shows a visible cell button at the hub of the needle after expulsion. The smear should be moderately cellular with cells distributed in a monolayer. Hemodiluted samples appear watery and produce smears with few cells and abundant red blood cells.

Prepare at least four to six slides from each aspirate. Two slides should be stained immediately with a Romanowsky-type stain such as Diff-Quik for preliminary evaluation. The remaining slides should be air-dried and stored for submission to a clinical pathologist. If the immediate evaluation shows low cellularity or excessive hemodilution, repeat the aspiration before the patient leaves the examination room.

Cellularity Scoring System

Use a simple cellularity scoring system to document sample quality:

  • Score 1: Acellular or very low cellularity, nondiagnostic
  • Score 2: Low cellularity, may be diagnostic but limited
  • Score 3: Moderate cellularity, adequate for interpretation
  • Score 4: High cellularity, excellent sample quality

Record the cellularity score for each aspirate. This information helps the clinical pathologist interpret the results and guides decisions about whether repeat sampling is needed. A study published in Berliner und Munchener tierarztliche Wochenschrift examined the reliability of lymph node cytology interpretation by investigators with limited cytologic experience. The findings indicated that interpretation accuracy improves with training and experience, highlighting the importance of submitting samples to qualified clinical pathologists [6].

Sample Handling for Flow Cytometry

When flow cytometry is anticipated, collect the aspirate into a tube containing media such as RPMI-1640 or phosphate-buffered saline with 1% fetal bovine serum. Keep the sample cool but not frozen during transport. Samples should be processed within 24 to 48 hours for optimal cell viability.

A multicenter flow cytometry proficiency testing study of canine blood and lymph node samples demonstrated the importance of standardized protocols and quality control measures across laboratories [9]. Ensure that the receiving laboratory provides specific instructions for sample collection and transport. Some laboratories accept samples in EDTA tubes for flow cytometry, but cell viability may be lower than in specialized media.

Troubleshooting Nondiagnostic Results

Common Causes of Nondiagnostic Cytology

Nondiagnostic cytology results occur in 10% to 20% of lymph node aspirates in clinical practice. The most common causes include:

  • Hemodilution from blood contamination during aspiration
  • Low cellularity from inadequate needle placement or insufficient negative pressure
  • Poor smear preparation with thick or uneven cell distribution
  • Necrotic or cystic lymph node contents with few viable cells
  • Fibrotic lymph nodes that yield few cells on aspiration

When a nondiagnostic result is obtained, review the sampling technique and repeat the aspiration. If the node feels fibrotic or necrotic on repeat palpation, consider excisional biopsy instead of repeat aspiration. Fibrotic nodes may yield poor-quality aspirates regardless of technique.

Addressing Discrepancies Between Cytology and Clinical Presentation

When cytology results do not match the clinical presentation, pursue additional testing before making treatment decisions. A case report published in the Journal of Veterinary Clinics described a 12-year-old dog with multicentric lymphadenopathy where cytology showed different cell populations across lymph nodes, including intermediate to large lymphocytes with frequent Mott cells. The presence of Mott cells along with immature lymphocytes made cytologic diagnosis challenging. Flow cytometry, along with PCR for Antigen Receptor Rearrangement (PARR) assay, confirmed the diagnosis of canine multicentric large B-cell lymphoma [12].

Specific scenarios that warrant additional testing include:

  • Cytology shows reactive hyperplasia but lymphadenopathy is progressive or asymmetric
  • Cytology shows a mixed population but clinical suspicion for lymphoma is high
  • Different lymph nodes show different cytologic features
  • Cytology is equivocal and the patient has systemic signs such as fever or weight loss

In these situations, proceed to flow cytometry or excisional biopsy instead of repeating cytology. The additional information from these tests often resolves the diagnostic uncertainty.

Managing Samples with Low Cellularity

Low cellularity samples may still provide diagnostic information if the cells present are characteristic. A single cluster of neoplastic cells can be diagnostic for metastatic disease. However, low cellularity samples cannot reliably rule out neoplasia. If the sample shows only a few small lymphocytes, the result should be reported as nondiagnostic instead of interpreted as reactive hyperplasia.

For flow cytometry, samples with fewer than 5000 events may not yield reliable results. The laboratory should report the total event count and cell viability along with the immunophenotype results. Samples with low viability or insufficient cell numbers should be interpreted with caution.

Record System for Lymph Node Sampling

Standardized Sampling Documentation

Create a standardized lymph node sampling record for each patient. Include the following fields:

  • Patient identification and signalment
  • Date and time of sampling
  • Lymph node site sampled (specific chain and side)
  • Palpation grade before sampling
  • Needle gauge and syringe size used
  • Number of slides prepared
  • Cellularity score at collection
  • Immediate stain results if performed
  • Sample handling and transport method
  • Laboratory receiving the sample
  • Expected turnaround time

This record allows tracking of sampling history and helps identify patterns of nondiagnostic results that may indicate a need for technique improvement.

Serial Sampling Documentation

For patients requiring serial sampling, maintain a chronological record of all lymph node aspirates. Document which nodes were sampled at each visit and the results. This is particularly important for patients with reactive hyperplasia that is being monitored over time. If a previously reactive node becomes progressively enlarged, repeat sampling may detect transformation to neoplasia.

Use a lymph node map diagram to record the location and palpation grade of each node at each visit. This visual record helps identify changes in individual nodes over time and guides selection of the most appropriate node for repeat sampling.

Quality Improvement Tracking

Track the proportion of nondiagnostic samples over time to identify opportunities for technique improvement. A nondiagnostic rate above 20% suggests that sampling technique or slide preparation needs attention. Review the records to identify common factors in nondiagnostic cases, such as specific lymph node sites or patient characteristics.

Consider periodic review of cytology slides with a clinical pathologist to confirm that sample quality is adequate. The American Animal Hospital Association provides resources on standards of care in veterinary practice that include quality improvement recommendations [2].

Common Failure Patterns in Lymph Node Sampling

Sampling the Wrong Node

The most common failure pattern is sampling a node that does not represent the disease process. In multicentric disease, different nodes may show different stages of involvement. A node that appears reactive on palpation may yield reactive cytology while a more abnormal node elsewhere shows neoplasia.

To avoid this error, palpate all accessible nodes before selecting the sampling site. If multiple nodes are enlarged, sample the node that feels most abnormal. If all nodes feel similar, sample the largest node. If the initial result does not match the clinical picture, sample a different node before proceeding to more invasive testing.

Inadequate Needle Placement

Needle placement that is too superficial or too deep can yield nondiagnostic samples. The needle tip should be within the lymph node parenchyma, not in the capsule or surrounding tissue. Use the non-dominant hand to stabilize the node and guide needle placement. Redirect the needle several times within the node to sample different areas.

For small or deep nodes, use ultrasound guidance to confirm needle placement. This is particularly important for abdominal or thoracic lymph nodes that cannot be palpated. Ultrasound guidance improves diagnostic yield and reduces the risk of sampling adjacent structures.

Excessive Negative Pressure

Applying too much negative pressure during aspiration can cause cell rupture and hemodilution. Use gentle, intermittent suction instead of continuous high negative pressure. Release suction before withdrawing the needle to prevent aspiration of the sample into the syringe barrel.

For highly cellular nodes, a non-aspiration technique may yield better samples. Insert the needle into the node and redirect it several times without applying suction. Cells enter the needle by capillary action and are expelled onto slides. This technique reduces hemodilution and cell damage.

Delayed Sample Processing

Delays in sample processing can compromise cell viability and affect flow cytometry results. Samples should be processed within 24 to 48 hours of collection. If immediate processing is not possible, store samples at 4 degrees Celsius in appropriate media. Do not freeze samples intended for flow cytometry.

For cytology slides, air-dry immediately after preparation and store in slide boxes to protect from dust and moisture. Staining can be delayed for several days if slides are properly stored. However, delay in staining may affect stain quality and interpretation.

Professional Escalation Criteria for Sampling Challenges

When to Request Specialist Assistance

Refer to a veterinary oncologist or internal medicine specialist when:

  • Two or more nondiagnostic aspirates have been obtained from the same patient
  • The lymph node is located in a difficult-to-access site such as the mediastinum or abdomen
  • Ultrasound guidance is needed for sampling but is not available in-house
  • The patient has a coagulopathy that increases bleeding risk
  • The clinical presentation suggests a rare or complex condition that requires specialized diagnostic testing

The American College of Veterinary Anesthesiologists and Analgesia offers guidance on anesthesia and pain management for surgical procedures [3]. For patients requiring sedation or anesthesia for lymph node sampling, consult with a veterinary anesthesiologist if the patient has significant comorbidities.

When to Proceed Directly to Biopsy

Proceed directly to excisional biopsy without repeat cytology when:

  • The lymph node is the only accessible node and previous aspiration was nondiagnostic
  • The node is small and difficult to aspirate accurately
  • The clinical suspicion for lymphoma is high and cytology is unlikely to change the diagnostic plan
  • The patient requires general anesthesia for other procedures and biopsy can be performed concurrently
  • The client prefers a definitive diagnosis from a single procedure

Excisional biopsy provides tissue architecture information that cannot be obtained from cytology or flow cytometry. The decision to proceed directly to biopsy should be based on the clinical context and client preferences.

When to Repeat Sampling

Repeat sampling is appropriate when:

  • The initial sample was hemodiluted or of low cellularity
  • The clinical presentation has changed since the initial sampling
  • A different lymph node has become more enlarged since the initial sampling
  • The initial result was equivocal and additional testing is needed
  • The client prefers to attempt less invasive sampling before proceeding to biopsy

Set a clear threshold for when repeat sampling is no longer appropriate. If two attempts at cytology are nondiagnostic, proceed to flow cytometry or biopsy. Repeated nondiagnostic sampling delays diagnosis and increases client costs without providing additional information.

Welfare and Safety Considerations in Sampling

Patient Comfort and Restraint

Lymph node aspiration is a minimally invasive procedure that can be performed with minimal restraint in most patients. Use a 22- to 25-gauge needle to minimize discomfort. For patients that are painful or anxious, consider sedation with a short-acting agent such as butorphanol or dexmedetomidine.

The World Organisation for Animal Health provides guidelines for animal health and welfare that include recommendations for minimizing stress during veterinary procedures [5]. Allow the patient to acclimate to the examination room before sampling. Use gentle restraint techniques and avoid prolonged restraint that causes distress.

Infection Control

Infectious lymphadenitis may be caused by zoonotic organisms such as Mycobacterium, Brucella, or Yersinia. Use standard precautions when handling lymph node samples. Wear gloves and eye protection during aspiration and slide preparation. Dispose of needles and syringes in sharps containers immediately after use.

If an infectious cause is suspected, notify the laboratory before submitting samples so that appropriate biosafety precautions can be taken. The American Veterinary Medical Association offers resources on animal health and welfare that include guidance on infectious disease surveillance [1].

Bleeding Risk Assessment

Assess bleeding risk before lymph node aspiration, particularly in patients with thrombocytopenia, coagulopathies, or those receiving anticoagulant therapy. Palpate the node gently to assess for pulsation that may indicate proximity to a blood vessel. If the patient has a known coagulopathy, consider ultrasound guidance to avoid vascular structures.

For patients with severe thrombocytopenia or coagulopathy, excisional biopsy under general anesthesia with appropriate hemostatic support may be safer than blind aspiration. Consult with a veterinary internist or anesthesiologist before proceeding with sampling in these patients.

Implementation Steps for the Decision Framework

Step 1: Pre-Sampling Assessment

Perform a complete physical examination with systematic lymph node palpation. Record the palpation grade for each node chain. Identify the largest and most abnormal node for sampling. Assess the patient for bleeding risk and need for sedation.

Step 2: Sample Collection

Select the appropriate needle gauge and syringe size based on the node size and location. Use gentle negative pressure and redirect the needle several times within the node. Prepare multiple slides and assess sample quality immediately. If the sample is hemodiluted or of low cellularity, repeat the aspiration.

Step 3: Sample Handling and Submission

Prepare slides for cytology and collect additional samples for flow cytometry if indicated. Label all samples with patient identification, date, and site. Complete the laboratory submission form with relevant clinical history. Transport samples to the laboratory according to their specific requirements.

Step 4: Result Interpretation and Follow-Up

Review cytology results with the clinical history and physical examination findings. If results are consistent with the clinical picture, proceed with appropriate treatment or monitoring. If results are equivocal or inconsistent, proceed to flow cytometry or biopsy as indicated.

Step 5: Documentation and Quality Improvement

Record all sampling details in the patient record. Track the proportion of diagnostic samples over time. Review nondiagnostic cases to identify opportunities for technique improvement. Consult with a clinical pathologist if sampling quality is consistently poor.

Frequently Asked Questions

What is the difference between reactive hyperplasia and lymphoma on cytology?

Reactive hyperplasia shows a mixed population of lymphocytes at various stages of maturation with increased plasma cells and macrophages. Lymphoma typically shows a monomorphic population of neoplastic lymphocytes that are similar in size and appearance. Well-differentiated lymphoma can be difficult to distinguish from reactive hyperplasia on cytology alone, which is why flow cytometry or biopsy may be needed.

When should I use flow cytometry instead of cytology?

Flow cytometry is indicated when cytology is equivocal, when a mixed cell population makes interpretation difficult, or when immunophenotype information is needed for prognosis and treatment planning. It is particularly useful for differentiating reactive from neoplastic populations and for classifying lymphoma subtypes.

How many lymph nodes should I aspirate in a patient with generalized lymphadenopathy?

Aspirate the largest and most accessible lymph node first. If the cytology is consistent with the clinical presentation, additional nodes may not be needed. If different nodes feel different on palpation or if the initial cytology is equivocal, aspirate multiple nodes. Different lymph nodes can show different cell populations in some cases.

What are the risks of lymph node biopsy?

Risks include hemorrhage, infection, seroma formation, and anesthetic complications. The risk is low with careful surgical technique and appropriate patient selection. Patients with coagulopathies should be evaluated before biopsy. The benefits of definitive diagnosis typically outweigh the risks.

Can flow cytometry be performed on stored samples?

Flow cytometry requires viable cells for optimal results. Samples should be processed within 24 to 48 hours of collection. Samples can be stored in appropriate media at 4 degrees Celsius for short-term storage. Freezing or prolonged storage compromises cell viability and may affect results.

What is the sentinel lymph node and why is it important?

The sentinel lymph node is the first lymph node to receive lymphatic drainage from a primary tumor. Identification and biopsy of the sentinel node allows detection of early metastatic disease that may not be apparent on routine examination. This technique improves staging accuracy and guides treatment decisions in veterinary surgical oncology.

How do I interpret flow cytometry results for lymph node samples?

Flow cytometry results show the percentage of cells positive for each marker in the panel. A monotypic population expressing a single light chain or showing aberrant antigen expression supports a diagnosis of neoplasia. Reactive populations show a mixture of B cells and T cells with polytypic light chain expression. Interpretation should be performed by a qualified clinical pathologist.

What follow-up is needed for a patient with reactive lymphadenopathy?

Patients with reactive lymphadenopathy should be re-examined in 2 to 4 weeks to document resolution. If lymphadenopathy persists or progresses, repeat cytology or proceed to biopsy. Address any underlying causes such as infection or inflammation. Monitor for development of systemic signs that may indicate progression to neoplasia.

Related Veterinary Guides

References and Further Reading

This article is educational and is not a substitute for veterinary diagnosis or treatment. Contact a veterinarian for advice about an individual animal.